Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Factors associated with stellate ganglion block success in recurrent ventricular arrhythmias

F. Chouairi, M. Fudim, A. Benak, JP. Piccini, J. Toman, J. Kautzner, A. Ganesh, M. Sramko

. 2025 ; 12 (1) : 110-117. [pub] 20240910

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010132

AIMS: One treatment option for refractory ventricular arrythmias is stellate ganglion block (SGB). We examined differences in SGB success by patient and arrhythmia characteristics and predictors of successful SGB. METHODS AND RESULTS: This was a multicenter analysis of patients treated for refractory ventricular arrythmias in the Czech Republic and the United States. The primary outcome was absence of ventricular arrythmias at 24 h post SGB. SGB effectiveness was examined according to aetiology of cardiomyopathy, arrhythmia type, laterality of SGB, presence of inotropes, and presence of mechanical circulatory support. Binary logistic regression was used to examine variables associated with the primary outcome. In total there were 117 patients with refractory ventricular arrythmias treated with SGB. Overall, the mean age was 63.5 ± 11.0 years, majority of patients were male (94.0%), White (87.2%), and had an implantable cardioverter defibrillator in situ (70.1%). There were no differences in efficacy of SGB based on aetiology of cardiomyopathy (P = 0.623), arrhythmia type (0.852), laterality of block (P = 0.131), and presence of inotropes (P = 0.083). Multivariable analysis demonstrated that increased age was associated with decreased odds of SGB success (odds ratio: 0.96, confidence interval: 0.92-0.99, P = 0.039) whereas increased left ventricular ejection fraction trended towards increased odds of SGB success (odds ratio: 1.05, confidence interval: 0.995-1.11, P = 0.077). CONCLUSIONS: In this multicentre experience, SGB was similarly effective despite the aetiology of cardiomyopathy, type of arrhythmia, laterality, and inotropic or mechanical support. SGB was less effective for the suppression of ventricular arrythmias at 24 h for the elderly.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010132
003      
CZ-PrNML
005      
20250429135459.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ehf2.15072 $2 doi
035    __
$a (PubMed)39253899
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Chouairi, Fouad $u Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA
245    10
$a Factors associated with stellate ganglion block success in recurrent ventricular arrhythmias / $c F. Chouairi, M. Fudim, A. Benak, JP. Piccini, J. Toman, J. Kautzner, A. Ganesh, M. Sramko
520    9_
$a AIMS: One treatment option for refractory ventricular arrythmias is stellate ganglion block (SGB). We examined differences in SGB success by patient and arrhythmia characteristics and predictors of successful SGB. METHODS AND RESULTS: This was a multicenter analysis of patients treated for refractory ventricular arrythmias in the Czech Republic and the United States. The primary outcome was absence of ventricular arrythmias at 24 h post SGB. SGB effectiveness was examined according to aetiology of cardiomyopathy, arrhythmia type, laterality of SGB, presence of inotropes, and presence of mechanical circulatory support. Binary logistic regression was used to examine variables associated with the primary outcome. In total there were 117 patients with refractory ventricular arrythmias treated with SGB. Overall, the mean age was 63.5 ± 11.0 years, majority of patients were male (94.0%), White (87.2%), and had an implantable cardioverter defibrillator in situ (70.1%). There were no differences in efficacy of SGB based on aetiology of cardiomyopathy (P = 0.623), arrhythmia type (0.852), laterality of block (P = 0.131), and presence of inotropes (P = 0.083). Multivariable analysis demonstrated that increased age was associated with decreased odds of SGB success (odds ratio: 0.96, confidence interval: 0.92-0.99, P = 0.039) whereas increased left ventricular ejection fraction trended towards increased odds of SGB success (odds ratio: 1.05, confidence interval: 0.995-1.11, P = 0.077). CONCLUSIONS: In this multicentre experience, SGB was similarly effective despite the aetiology of cardiomyopathy, type of arrhythmia, laterality, and inotropic or mechanical support. SGB was less effective for the suppression of ventricular arrythmias at 24 h for the elderly.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a blokáda autonomních nervů $x metody $7 D001340
650    12
$a ganglion stellatum $7 D013233
650    _2
$a výsledek terapie $7 D016896
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a recidiva $7 D012008
650    _2
$a následné studie $7 D005500
650    _2
$a komorová tachykardie $x terapie $x patofyziologie $x etiologie $7 D017180
650    _2
$a senioři $7 D000368
651    _2
$a Spojené státy americké $x epidemiologie $7 D014481
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Fudim, Marat $u Department of Internal Medicine, Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA $u Duke Clinical Research Institute, Durham, North Carolina, USA
700    1_
$a Benak, Ales $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Piccini, Jonathan P $u Department of Internal Medicine, Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA $u Duke Clinical Research Institute, Durham, North Carolina, USA
700    1_
$a Toman, Jakub $u Department of Internal Medicine, Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA
700    1_
$a Kautzner, Josef $u Department of Internal Medicine, Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA
700    1_
$a Ganesh, Arun $u Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA
700    1_
$a Sramko, Marek $u Department of Internal Medicine, Division of Cardiology, Duke University School of Medicine, Durham, North Carolina, USA
773    0_
$w MED00197251 $t ESC heart failure $x 2055-5822 $g Roč. 12, č. 1 (2025), s. 110-117
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39253899 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135454 $b ABA008
999    __
$a ok $b bmc $g 2311484 $s 1247213
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 12 $c 1 $d 110-117 $e 20240910 $i 2055-5822 $m ESC heart failure $n ESC Heart Fail $x MED00197251
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace